STAAR Surgical (NASDAQ:STAA) Major Shareholder Broadwood Partners, L.P. Purchases 108,720 Shares

STAAR Surgical (NASDAQ:STAA - Get Free Report) major shareholder Broadwood Partners, L.P. bought 108,720 shares of the business's stock in a transaction on Thursday, March 20th. The shares were acquired at an average cost of $17.96 per share, with a total value of $1,952,611.20. Following the purchase, the insider now owns 12,182,995 shares of the company's stock, valued at $218,806,590.20. The trade was a 0.90 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Tuesday, March 18th, Broadwood Partners, L.P. acquired 93,124 shares of STAAR Surgical stock. The shares were acquired at an average cost of $17.54 per share, with a total value of $1,633,394.96.
• On Monday, March 3rd, Broadwood Partners, L.P. bought 249,503 shares of STAAR Surgical stock. The shares were bought at an average cost of $16.64 per share, with a total value of $4,151,729.92.
• On Thursday, February 27th, Broadwood Partners, L.P. purchased 259,316 shares of STAAR Surgical stock. The stock was bought at an average cost of $17.05 per share, for a total transaction of $4,421,337.80.
• On Friday, February 14th, Broadwood Partners, L.P. acquired 36,532 shares of STAAR Surgical stock. The shares were bought at an average cost of $15.49 per share, with a total value of $565,880.68.
• On Wednesday, February 12th, Broadwood Partners, L.P. bought 259,616 shares of STAAR Surgical stock. The stock was purchased at an average cost of $14.96 per share, for a total transaction of $3,883,855.36.
• On Thursday, January 16th, Broadwood Partners, L.P. purchased 8,221 shares of STAAR Surgical stock. The shares were purchased at an average price of $21.50 per share, with a total value of $176,751.50.
• On Tuesday, January 14th, Broadwood Partners, L.P. acquired 21,155 shares of STAAR Surgical stock. The stock was purchased at an average price of $21.46 per share, for a total transaction of $453,986.30.

STAAR Surgical Trading Up 0.3 %

STAA stock traded up $0.05 during trading on Monday, hitting $17.77. 880,160 shares of the company's stock were exchanged, compared to its average volume of 765,994. The stock has a market capitalization of $876.51 million, a price-to-earnings ratio of -43.34 and a beta of 0.66. STAAR Surgical has a 52-week low of $13.50 and a 52-week high of $52.68. The business has a 50-day moving average price of $19.77 and a two-hundred day moving average price of $25.52.

Remove Ads

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. BTIG Research lowered shares of STAAR Surgical from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 12th. Stifel Nicolaus cut their target price on shares of STAAR Surgical from $38.00 to $20.00 and set a "buy" rating on the stock in a research note on Wednesday, February 12th. William Blair cut shares of STAAR Surgical from an "outperform" rating to a "market perform" rating in a research report on Wednesday, February 12th. Mizuho lowered STAAR Surgical from an "outperform" rating to a "neutral" rating and cut their price objective for the stock from $45.00 to $17.00 in a research report on Wednesday, February 12th. Finally, Stephens reiterated an "equal weight" rating and issued a $17.00 price objective on shares of STAAR Surgical in a research note on Tuesday, March 18th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $25.29.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in STAA. Quarry LP purchased a new stake in STAAR Surgical in the third quarter valued at approximately $50,000. Quest Partners LLC purchased a new stake in STAAR Surgical in the 3rd quarter valued at $128,000. Larson Financial Group LLC boosted its stake in STAAR Surgical by 78.3% during the 3rd quarter. Larson Financial Group LLC now owns 4,863 shares of the medical instruments supplier's stock worth $181,000 after purchasing an additional 2,135 shares during the period. FMR LLC grew its position in STAAR Surgical by 79.3% during the 3rd quarter. FMR LLC now owns 7,092 shares of the medical instruments supplier's stock worth $263,000 after purchasing an additional 3,136 shares during the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new position in STAAR Surgical in the fourth quarter valued at $180,000. Hedge funds and other institutional investors own 96.70% of the company's stock.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.